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Abstract
Background: The interpretation of myocardial perfusion scintigraphy (MPS) largely relies on visual assessment by
the physician of the localization and extent of a perfusion defect. The aim of this study was to introduce the
concept of the perfusion vector as a new objective quantitative method for further assisting the visual
interpretation and to test the concept using simulated MPS images as well as patients.
Methods: The perfusion vector is based on calculating the difference between the anatomical centroid and the
perfusion center of gravity of the left ventricle. Simulated MPS images were obtained using the SIMIND Monte
Carlo program together with XCAT phantom. Four different-sized anterior and four lateral defects were simulated,
and perfusion vector components x-, y-, and z-axes were calculated. For the patient study, 40 normal and 80
abnormal studies were included. Perfusion vectors were compared between normal and abnormal (apical, inferior,
anterior, and lateral ischemia or infarction) studies and also correlated to the defect size.
Results: For simulated anterior defects, the stress perfusion vector component on the y-axis (anterior-inferior direction)
increased in proportion to the defect size. For the simulated lateral defects, the stress perfusion vector component on
the x-axis (septal-lateral direction) decreased in proportion to the defect size. When comparing normal and abnormal
patients, there was a statistically significant difference for the stress perfusion vector on the x-axis for apical and lateral
defects; on the y-axis for apical, inferior, and lateral defects; and on the z-axis (basal-apical direction) for apical, anterior,
and lateral defects. A significant difference was shown for the difference vector magnitude (stress/rest) between
normal and ischemic patients (p = 0.001) but not for patients with infarction. The correlation between the defect size
and stress vector magnitude was also found to be significant (p < 0.001).
Conclusions: The concept of the perfusion vector introduced in this study is shown to have potential in assisting the
visual interpretation in MPS studies. Further studies are needed to validate the concept in patients.
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Background
Myocardial perfusion scintigraphy (MPS) is a widely
used diagnostic method for the management of pa-
tients with suspected or known ischemic heart disease
[1–5]. Single-photon emission computed tomography
(SPECT) is used to generate three-dimensional images
of radioactive tracer distribution in the left ventricular
myocardium.
Software packages for quantification of perfusion data
and computer-aided diagnosis systems have been devel-
oped in order to make the interpretation of MPS studies
more standardized, both regarding left ventricular func-
tion and regarding perfusion data. For perfusion data, a
17- or 20-segment model is often used that evaluates
both the extent and severity of perfusion defects during
stress and rest, generating a summed stress score (SSS)
and a summed rest score (SRS). The difference (summed
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difference score (SDS)) indicates the degree of ischemia.
However, it has been shown that there is a considerable
variability in the scoring values between different soft-
ware packages [6–9], and this variability will affect the
calculated amount of ischemia. Therefore, the physician
interpreting the study will use both visual assessment
and scoring values for the determination of the
localization and amount of ischemia. Visual interpret-
ation has on the other hand been shown to be subject to
rather large inter- and intra-observer variability [10].
Hence, there is a need for new objective quantitative
methods to be used in adjunct to the visual analysis to
facilitate a correct diagnosis.
In this study, we have created a method that could
assist the visual interpretation in MPS studies. The
concept of the perfusion vector introduced here is
based on the centroid. The centroid is the geometric
center of gravity in a three-dimensional figure, in this
case, the left ventricle. The left ventricle is outlined
from SPECT images, and the anatomical and perfu-
sion centroids are calculated. The location of the
perfusion center of gravity will depend on the rela-
tive perfusion in the left ventricle. If the perfusion is
normal throughout the left ventricle, the perfusion
center of gravity and the anatomical centroid will be
located close to each other. The difference between the
anatomical and perfusion centroids is called the perfusion
vector and will be small if the perfusion is normal. If the
perfusion is not homogenous, the perfusion center of
gravity will deviate from the anatomical centroid and this
will result in a larger perfusion vector. The aim of this
study was to test the concept of the perfusion vector in
simulated MPS images and then to further validate the
method in a clinical setting.
Methods
Perfusion vector concept
The perfusion vector concept is based on a calcula-
tion of the difference between the anatomical centroid
and the perfusion center of gravity of the left ven-
tricle. The left ventricle is outlined from SPECT im-
ages using the EXINI Heart™ software (EXINI
Diagnostics AB, Lund, Sweden) and is represented by
a surface through the center of the myocardium. This
surface is a grid of rectangles where each rectangle is
assigned an index i, a center position (xi, yi, zi), an
area Ai, and a weight Wi. Figure 1 depicts this grid.
Given these definitions, the centroid of the left ven-
tricle myocardium is calculated using Eq. 1. By set-
ting Wi = 1 for all i, the formula reduces to the
geometrical centroid of the grid. A corresponding
perfusion center of gravity is calculated by setting
the weights Wi to the measured intensity at each
position (xi, yi, zi).
C ¼
X
xiAiW iX
AiWi
;
X
yiAiW iX
AiWi
;
X
ziAiW iX
AiWi
 !
ð1Þ
A perfusion vector is then calculated using Eq. 2.
P
→¼ Cp−CA ð2Þ
Here, CA is the anatomical centroid and CP is the per-
fusion center of gravity. Given a perfusion defect, the
vector
→
P would point away from the defect with a mag-
nitude corresponding to the severity and extent of the
defect, as shown in Fig. 2. The different axis directions
are defined according to Fig. 3. Several different mea-
surements are generated: the size of the perfusion vector
at rest and during stress, the direction of the vector
(expressed as x-, y-, and z-axes), and the difference be-
tween the stress and rest vector magnitudes.
Simulation study
The SIMIND Monte Carlo program [11] together with
the XCAT phantom [12] was used to simulate projection
data. A phantom representing a standard male with an
end diastolic volume of the left ventricle of 148 mL was
used. To simulate the beating heart and breathing mo-
tion, 40 static phantoms were created with the heart in
different spatial positions and positioned in the heart
cycle. Simulation was performed for each phantom and
Fig. 1 The left ventricle represented by a surface of rectangles
through the center of the myocardium
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then merged prior to reconstruction. Perfusion defects
were simulated as indicated in Fig. 4. Eight defects were
simulated, four anterior angles α of 10°, 30°, 50°, and 70°,
with a propagation in the apical-basal direction (x) of
6 cm, and four lateral defects of corresponding sizes.
Simulations without defects were also performed. For
each simulation, 32 projections in a 180° arc, starting at
45° right anterior oblique position, were created and a
128 × 128 matrix with a pixel size of 4.8 mm was used.
In order to mimic real measurements, the simulations
were performed with enough photons to avoid Monte
Carlo noise. Instead, Poisson noise was added after the
simulations, corresponding to measurements with an ad-
ministered activity of 600 MBq, an uptake of 1 % in the
heart and where every projection was measured for 20 s.
Tomographic images were then reconstructed using the
ordered subset expectation maximization (OSEM) algo-
rithm, four iterations, and eight subsets. A Gaussian post
filter was applied with a full width at half maximum
(FWHM) of 7 mm. Short-axis slices were created from the
trans-axial slices. Scatter and attenuation corrections were
not applied.
Study population
One thousand two hundred eighty-three patients re-
ferred for MPS in Malmö, Sweden, in 2007 were consid-
ered for inclusion. One of the investigators (ET)
categorized all patients into the following groups: nor-
mal studies, anterior infarction, apical infarction, lateral
infarction, inferior infarction, anterior ischemia, apical
ischemia, lateral ischemia, inferior ischemia, mixed de-
fects, multiple defects, equivocal studies, and stress-only
studies. The categorization was based on visual assess-
ment of the MPS images. Patients with mixed defects,
multiple defects, equivocal studies, and stress-only stud-
ies were excluded since well-defined defects were desir-
able in this first patient study. The first 10 patients (40
for normal studies) to be included in the categories were
used as the study population. Thus, 80 abnormal and 40
normal studies were included. EXINI Heart™ (EXINI
Diagnostics AB, Lund, Sweden) was used to automatic-
ally derive the size of ischemia and infarction for all pa-
tients based on their artificial neural network algorithm.
The study was approved by the local research ethics
committee at Lund University and complies with the
Declaration of Helsinki.
Fig. 2 The perfusion vector as the result of the difference between
the anatomical centroid, CA, and the perfusion center of gravity, CP
Fig. 3 The different axis directions for the perfusion vector
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MPS protocol
The MPS studies were performed using a 2-day gated
stress/non-gated rest Tc-99m-tetrofosmin protocol, starting
with injection of 600 MBq Tc-99m-tetrofosmin at
stress, followed by 600 MBq Tc-99m-tetrofosmin at
rest. Patients were stressed using either maximal exer-
cise on an ergometer or pharmacological test with
adenosine.
Stress and rest acquisitions began about 60 min after
the injection of Tc-99m-tetrofosmin. Images were ob-
tained according to established clinical protocols, using
SPECT over 180° elliptical and autocontour rotations
from the 45° right anterior oblique position, with a dual-
head gamma camera, e.cam (Siemens AG Medical Solu-
tions, Erlangen, Germany). Patients were imaged in the
supine position. Low-energy high-resolution collimator
and a zoom factor of 1.0 were used. We obtained 64 pro-
jections in a 128 × 128 matrix, with an acquisition time of
25 s per projection. Tomographic reconstruction and cal-
culation of short- and long-axis slice images were per-
formed using e.soft (Siemens AG Medical Solutions,
Erlangen, Germany). Images were reconstructed with fil-
tered back projection. A two-dimensional Butterworth
pre-reconstruction filter was used with cut-off frequency
of 0.45, order 5.
Statistical analysis
Kruskal-Wallis analyses were performed to investigate
differences in perfusion centroids between the normal
and abnormal patients. When significance was found,
Mann-Whitney analyses were carried out to test for dif-
ferences. Abnormal patients were compared to the nor-
mal patients; thus, multiple tests were performed. We
used a Bonferroni correction to give a significance level
of 0.0125 when four groups were tested and 0.025 when
two tests were carried out. Spearman’s correlation test
was performed to investigate differences between defect
extent and magnitude vector. All analyses were carried
out using MedCalc v 12.7.7 (MedCalc Software bvba,
Ostend, Belgium).
Results
Simulation study
The simulated MPS images for the different-sized anterior
and lateral defects are shown in Fig. 5. For anterior de-
fects, the stress perfusion vector on the y-axis (anterior-in-
ferior direction) increased according to the defect size,
whereas the vector on the x-axis and z-axis remained
stable (Fig. 6). For the lateral defects, the stress perfusion
vector on the x-axis (septal-lateral direction) decreased ac-
cording to the defect size, whereas the vectors on the y-
axis and z-axis remained reasonably stable (Fig. 7).
Patient study
In the normal patient group, there were 10 men and 30
women. Mean age was 59.3 years (range 35–88 years). For
the abnormal patients, 54 men and 26 women were in-
cluded. Mean age was 65.2 years (range 41–83 years). Mean
total extent of defects (automatically derived from EXINI
Heart™) was 0.17 % for normal patients (range 0–6.6 %)
and 25.0 % (range 0 to 64.4 %) for abnormal patients. For
ischemic patients, the mean extent of ischemia was 15.6 %
(range 0–37.4 %), and for infarcted patients, the mean ex-
tent of infarction was 29.8 % (range 0–64.0 %).
For the first analysis, stress perfusion vectors were
compared between normal patients and four different
groups of abnormal patients (apical, inferior, anterior,
and lateral ischemia or infarction) for the x-, y-, and z-
axes. As seen in Fig. 8, the range for normal patients
was small in all three orientations, whereas the ranges
were large in the abnormal patient groups. There was a
statistically significant difference between the normal and
the apical group and between the normal and the lateral
group on the x-axis, between the normal and the apical,
inferior and lateral groups on the y-axis, and between the
normal and the apical, anterior and lateral groups on the
z-axis. The correlation between the defect size and stress
vector magnitude (Fig. 9) was found to be statistically sig-
nificant, with an r value of 0.63. There was a statistically
significant difference in the difference (rest/stress) vector
magnitude between the normal patients and the ischemic
patients, but not between the normal patients and the pa-
tients with infarction (Fig. 10).
Discussion
Every day, physicians in radiology and nuclear medicine
are faced with interpreting challenging studies. In med-
ical imaging, visual interpretation of images is dependent
on the knowledge of the physician and is subject to
Fig. 4 Simulations of perfusion defects. For each defect location
(anterior and lateral), four simulations were created with an angle α of
10°, 30°, 50°, and 70°, with a propagation in the apical-basal direction
(x) of 6 cm
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Fig. 6 x, y, and z components of the stress perfusion vectors for the different sizes of simulated anterior defects
Fig. 5 The upper part of the figure shows the simulated anterior defects (the first figure without a defect) with an angle α of 10°, 30°, 50°, and
70°. The lower part of the figure shows the simulated lateral defects
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inter- and intra-observer variabilities. There is a strong
need for the development of automatic, quantitative
measurements to be used in addition to the visual inter-
pretation in order to help standardize interpretation and
facilitate a correct diagnosis.
In this study, we wanted to develop an automatic,
quantitative measurement in MPS studies, which could
assist the visual interpretation. We therefore introduced
the concept of perfusion vector, based on the difference
between the anatomical and perfusion-weighted cen-
troid. Based on the simulation studies, we found that for
anterior defects, the perfusion vector changed in the
anterior-inferior direction, in proportion to the size of
the defect. For the lateral defects, the perfusion vector
changed in the septal-lateral direction, in proportion to
the defect size.
After these encouraging simulation results, we wanted
to validate the method in a patient population. The
stress perfusion vector changed drastically for the pa-
tients with lateral defects on the x-axis, as expected. The
vector for the apical defects (which often is oriented to-
wards the septal-anterior part of the left ventricle) chan-
ged in the opposite direction. For the y-axis, the change
of the perfusion vector for the inferior defects was ori-
ented in the opposite direction compared to anterior de-
fects (not statistically significant compared to normal
patients). We found a significant difference also for pa-
tients with apical defects and lateral defects. Lateral de-
fects are often located slightly in the inferior part of the
left ventricle and apical defects often slightly in the an-
terior part of the left ventricle, which could explain these
results. Finally, for the z-axis, as expected, the perfusion
vector for the apical defects was significantly different
from the normal patients. The change in perfusion
vector on the z-axis for the anterior, inferior, and lateral
defects will depend on if the defects are located in the
basal or apical part of the left ventricle. Patients with ap-
ical defects were included as a separate group (although
often located towards the anterior part of the left ven-
tricle) in order to see if changes in the z-axis were
present.
The difference (stress/rest) vector could be used to dif-
ferentiate between patients with and without ischemia,
but there was a large inter-individual variability. The
vector magnitude correlated quite well with the auto-
matically derived extent of the defects.
There are several possible reasons for the large inter-
individual variability in the abnormal patients. The pa-
tients were selected only based on the main localization
of the defect, not based on the size of the perfusion de-
fects. Therefore, both small, medium-sized and large de-
fects are included in the material, and the mean defect
size is likely to be different for different groups. Also, pa-
tients tend not to have “perfect” distribution of tracer in
areas without perfusion defects. For example, if the de-
lineation of one part of the ventricle is slightly outside
the ventricle border, there is a lower uptake in one (or
more) of the basal part(s) of the ventricle, which affects
the calculated perfusion vector.
The most encouraging result from the patient study
was the small variation in all three orientations for the
normal patients compared to the abnormal patients. It is
possible that the method could be useful for the deter-
mination if a study is normal. This could for example fa-
cilitate the determination if a rest study is needed after a
stress study, but this needs to be further tested. In this
study, no attenuation-corrected images were studied. It
is unknown how the perfusion vector method works in
Fig. 7 x, y, and z components of the stress perfusion vectors for the different sizes of simulated lateral defects
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attenuation-corrected images, but one hypothesis is
that the variation in different orientations for the nor-
mal patients will be even smaller due to a more
homogenous tracer uptake in attenuation-corrected
images. An advantage of the perfusion vector concept
is that the method is fully automated and thus elimi-
nates subjective assessment of the images.
Study limitations
For the normal group, we used patients that were admit-
ted for clinical MPS due to suspicion of coronary artery
disease but were interpreted as normal. It would be pre-
ferred to use a normal population, with a low likelihood
of coronary artery disease. Only a limited number of
patients with ischemia and infarction were included. We
also do not have any other method, such as invasive cor-
onary angiography with fractional flow reserve measure-
ments, to validate the interpretation of SPECT images.
Conclusions
The concept of the perfusion vector introduced in this
study is shown to have potential in assisting the visual
interpretation in MPS studies. The small variation in
Fig. 8 Box plots for the stress perfusion vectors for normal patients
and patients with ischemia or infarction at different locations (apical,
inferior, anterior, lateral) for the x-axis (a), y-axis (b), and z-axis (c).
The p value is related to the normal group
Fig. 9 Comparison between stress vector magnitude and automatically
derived defect extent
Fig. 10 Box plots for the difference magnitude for normal patients,
as well as patients with ischemia and infarction. The p value is
related to the normal group
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normal patients compared to the abnormal patients
could prove to be helpful to determine if a study is to be
considered normal and without perfusion defects. For
the abnormal studies, there was a gradual change of the
perfusion vector correlating to the size of the perfusion
defect, both in simulated images and in patient studies.
Hence, here, the perfusion vector could assist when
assessing the size of a perfusion defect. Further studies
are needed to validate the concept in patients.
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